Kazia Therapeutics Ltd ADR logo

Kazia Therapeutics Ltd ADR

KZIA | NASDAQ
Chart Builder DCF Calculator
$10.92
+$0.27 (+2.54%)
At close: Sep 22, 2026, 4:00 PM ET
$10.73
-$0.19 (-1.77%)
After-hours: Sep 22, 2026, 7:35 PM ET

Market Data

Market Cap
$17.25M
Enterprise Value
$-43.44M
Beta
2.15
Average Volume
223.69K
Shares Outstanding (Diluted)
3.12M
Shares Change YoY
550.63%
Institutional Ownership
56.21%
Exchange
NASDAQ
ISIN
US48669G3039

Price Performance

Price Change 1M
-20.3%
Price Change 3M
-27.5%
Price Change 6M
45.9%
Price Change YTD
113.0%
Price Change 1Y
41.6%
Price Change 3Y
-79.3%
Price Change 5Y
-98.1%
1M CAGR (ann.)
-23.3%
1Y CAGR (ann.)
37.8%
5Y CAGR (ann.)
-54.0%
All-Time CAGR
-25.3%

Valuation

PE Ratio
-1.59
Forward PE
N/A
PEG Ratio
-0.02
Forward PEG
-0.04
PS Ratio
1,355.89
Forward PS
41.90
PB Ratio
0.56
P/FCF Ratio
-2.95
P/Adj. FCF Ratio
-2.95
P/OCF Ratio
-3.89
EV/Sales
-2,204.00
EV/EBIT
2.39
EV/EBITDA
2.39
EV/FCF
4.79
Earnings Yield
-69.0%
FCF Yield
-37.3%
Adj. FCF Yield
-37.3%

Financial Health

Net Cash
A$69.29M
Total Debt
A$98.71K
Cash & Short-Term Investments
A$69.39M
Total Assets
A$71.04M
Current Ratio
2.87
Quick Ratio
2.87
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.01
Debt / FCF
-0.01
OCF / Debt
-133.90
Interest Coverage
0.00
Altman Z-Score
-2.31
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-92086.4%
EBITDA Margin
-92086.4%
Net Profit Margin
-113004.6%
FCF Margin
-46038.4%
Adj. FCF Margin
-46038.4%
SBC / Revenue
0.0%
SBC Impact (per share)
N/A

Returns

Return on Assets
-31.4%
Return on Equity
-116.9%
Return on Invested Capital
-36.2%
Return on Capital Employed
-38.9%
Return on Tangible Assets
-31.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
-75.2%
Revenue CAGR 5Y
-63.8%
Revenue CAGR 10Y
-48.7%
EPS CAGR 3Y
71.7%
EPS CAGR 5Y
29.5%
EPS CAGR 10Y
36.6%
FCF CAGR 3Y
-4.2%
FCF CAGR 5Y
-2.7%
FCF CAGR 10Y
1.7%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
3
EPS Growth Next 3Y
25.1%
Revenue Growth Next 3Y
293.0%
Earnings Date
Mar 1, 2027
EPS Estimate (next Q)
-$0.32
EPS Growth Est (next Q)
-22.0%
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$31.50
Price Target Upside
195.8%

Cash Flow

Operating Cash Flow
A$-13.22M
Free Cash Flow
A$-9.07M
Adj. Free Cash Flow
A$-9.07M
FCF Per Share
-$2.91
OCF Per Share
-$4.24
OCF/S Ratio
-67055.4%

Income Statement

Revenue
A$19.71K
Gross Profit
A$19.71K
Operating Income
A$-18.15M
EBITDA
A$-18.15M
Net Income
A$-22.27M
EPS (Diluted)
-$10.35
Revenue / Employee
$3.29K
Profit / Employee
$-3.71M
Employees
6

© 2026 bestshares.com. All rights reserved.